申请人:Lan-Hargest Hsuan-Yin
公开号:US20120035257A1
公开(公告)日:2012-02-09
Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, such as, for example, a hydroxamic acid group or a carboxylic acid group, can inhibit histone deacetylase. Histone deacetylase can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.
组蛋白去乙酰化酶是一种含有锌活性位点的金属酶。具有锌结合基团(例如羟肟酸基团或羧酸基团)的化合物可以抑制组蛋白去乙酰化酶。组蛋白去乙酰化酶可以抑制基因表达,包括与肿瘤抑制相关的基因表达。因此,抑制组蛋白去乙酰化酶可以提供一种替代途径来治疗癌症、血液疾病(例如血红蛋白病)和遗传相关代谢疾病(例如囊性纤维化和肾上腺白质营养不良症)。